Macerich to Present at BofA Securities 2024 Global Real Estate Conference SANTA MONICA, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) today announced that Jack Hsieh, President and Chief Executive Officer, Scott Kingsmore, Senior Executive Vice President and Chief Financial Officer, and Doug Healey, Senior Executive Vice President Leasing will present to/speak with investors at BofA Securities 2024 Global Real Estate Conference in New York, NY September 10-11, 2024. Macerich will present at 1:30 p.m. Eastern on Tuesday, September 10, 2024. The live audio...
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference WESTLAKE VILLAGE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that , President, Chairman and CEO, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at the H.C. Wainwright Global Healthcare Conference, taking place September 9-11, 2024, in New York City, New York. The conversation with Emily Bodnar, Vice President, Equity Research and H.C. Wainwright Biotechnology Analyst, is s...
Macerich Releases 2023 Corporate Responsibility Report Report marks 15 years of industry-leading sustainability strategy by leading retail real estate company SANTA MONICA, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation's leading owners, operators and developers of major retail properties in top markets, today released its 2023 Corporate Responsibility Report, with data for the period ending December 31, 2023. This year’s “Together for Tomorrow” theme emphasizes the company’s environmental sustainability, social and governance efforts in service of its...
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2024 and provided general business updates. “The past quarter has continued to be transformative for the company as we completed a key financing expected to provide runway through three trial readouts, including our ongoing Phase 3 trial in platinum resistant/refractory ovarian cancer,” said , President...
A director at Alpine Select AG sold/bought 6,500 shares at 7.550CHF and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Macerich Reports Second Quarter 2024 Results SANTA MONICA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) has released its Second Quarter 2024 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at . As previously announced, management will hold a conference call at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) today, Wednesday, July 31, 2024, to discuss quarterly results. Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial...
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024 WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at BTIG’s Virtual Biotechnology Conference 2024. The conversation with Kaveri Pohlman, PhD, Director and BTIG Biotechnology Analyst, is scheduled to begin at 12:00 p.m. ET on Tuesday, August 6, 2024. ...
Macerich Declares the Quarterly Dividend on Its Common Shares SANTA MONICA, Calif., July 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $.17 per share of common stock. The dividend is payable on September 9, 2024, to stockholders of record at the close of business on August 19, 2024. About Macerich Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractiv...
Macerich Announces the Return of Diana M. Laing to Board of Directors Laing Previously Served on Macerich Board from 2003-2022; Was Board Member at Spirit Realty Capital During Macerich President and CEO Jackson Hsieh’s Successful Tenure at the Company SANTA MONICA, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced the appointment of Diana M. Laing to its Board of Directors. Ms. Laing previously served on Macerich’s Board from 2003 through 2022. With the ad...
Macerich Schedules Second Quarter 2024 Earnings Release and Conference Call SANTA MONICA, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules Second Quarter 2024 Earnings Release and Conference Call WHEN: Earnings Results will be released before market open on Wednesday, July 31, 2024. Management will hold a conference call at 10:00 am Pacific Time (1:00 pm Eastern Time) on that same day to discuss quarterly results. WHERE: Participants who wish to join the conference by telephone must register at the dial-in registration link below to rece...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.